Albireo Pharma, Inc.
ALBONASDAQHealthcare
$44.15
+$0.00(+0.00%)
Market Cap$915887335
P/E Ratio—
52W High$45.23
52W Low$16.02
Albireo Pharma, Inc. (ALBO) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ALBO · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2021-12 | 2020-12 | 2019-12 | 2018-12 | 2017-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $40.58M | $8.31M | $9.64M | $12.74M | $0.00M |
| Cost of Revenue | $1.36M | $0.00M | $2.21M | $0.00M | $0.00M |
| Gross Profit | $39.22M | $8.31M | $7.43M | $12.74M | $0.00M |
| Gross Margin %(computed) | 96.66% | 100.00% | 77.07% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $82.52M | $76.78M | $45.58M | $31.73M | $12.99M |
| G&A Expenses | $0.00M | $42.45M | $22.96M | $18.06M | $15.25M |
| Total Operating Expenses | $162.71M | $104.58M | $70.75M | $50.63M | $24.58M |
| Operating Income | ($123.48M) | ($96.27M) | ($61.11M) | ($37.89M) | ($24.58M) |
| Operating Margin %(computed) | -304.31% | — | -634.21% | -297.41% | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $13.93M | $11.36M | $5.30M | $0.00M | $0.04M |
| Income Before Tax | ($34.03M) | ($107.63M) | ($62.72M) | ($46.09M) | ($24.20M) |
| Income Tax Expense | $117.32M | $11.36M | $8.99M | $0.02M | $0.21M |
| Net Income | ($151.35M) | ($119.00M) | ($71.70M) | ($46.11M) | ($24.41M) |
| Net Margin %(computed) | -372.97% | — | -744.13% | -361.94% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-7.87 | $-7.45 | $-5.77 | $-3.94 | $-3.12 |
| Wtd Avg Shares | 19.22M | 15.98M | 12.44M | 11.70M | 7.82M |
| EBITDA | ($19.82M) | ($96.08M) | ($57.29M) | ($37.84M) | ($24.13M) |
| EBITDA Margin %(computed) | -48.85% | — | -594.58% | -297.06% | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Albireo Pharma, Inc. data
About Albireo Pharma, Inc. (ALBO) Income Statement
Albireo Pharma, Inc. (ALBO) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2021, ALBO reported revenue of $0.04B, gross profit of $0.04B (gross margin 96.66%), and net income of ($0.15B) — a net profit margin of -372.97%.
Frequently asked questions
ALBO · 4 questionsAlbireo Pharma, Inc. (ALBO) reported revenue of $0.04B for 2021, up 388.4% year-over-year.
ALBO revenueALBO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09